Skip to main content
. 2019 Jun 28;9:235. doi: 10.3389/fcimb.2019.00235

Figure 3.

Figure 3

Impact of in vitro infection of monocyte-enriched PBMCs with T. gondii on subset distribution and expression of CD14 and CD16 of monocytes from blood donors with or without chronic toxoplasmosis. (A) Monocyte-enriched PBMCs were isolated from blood samples and were either directly FACS-analyzed (0 h) or cultivated in vitro for 48 h and parasite-infected or not during the final 24 h as indicated and then FACS-analyzed. (B–D) Percentages of CD14+CD16 (B), CD14+CD16+ (C) and CD14dimCD16+ (D) subsets among monocytes from T. gondii seropositive (gray bars) or seronegative (open bars) individuals. (E,F) Expression levels of CD14 (E) and CD16 (F) on monocytes from T. gondii seropositive or seronegative blood donors. Data represent means ± S.E.M. from 5 T. gondii seropositive and from 13 out of 16 seronegative blood donors which had been randomly selected for in vitro infection assays; outlyers were excluded. Individual data points are also indicated. Significant differences between groups were identified by ANOVA (***p < 0.001; **p < 0.01; *p < 0.05).